Pluronic® block copolymers: Novel functional molecules for gene therapy

Alexander V. Kabanov, Pierre Lemieux, Sergey Vinogradov, Valery Alakhov

Research output: Contribution to journalArticle

267 Citations (Scopus)

Abstract

Pluronic® block copolymers are recognized pharmaceutical excipients listed in the US and British Pharmacopoeia. They have been used extensively in a variety of pharmaceutical formulations including delivery of low molecular mass drugs and polypeptides. This review describes novel applications of Pluronic® block copolymers in gene therapy. In particular, these molecules can modify the biological response during gene therapy in the skeletal muscle, resulting in an enhancement of the transgene expression as well as an enhancement of the therapeutic effect of the transgene. Furthermore, Pluronic® block copolymers are versatile molecules that can be used as structural elements of the polycation-based gene delivery systems (polyplexes). Based on these studies, the use of block copolymers in gene delivery is a promising area of research, in which new and important developments are expected.

Original languageEnglish (US)
Pages (from-to)223-233
Number of pages11
JournalAdvanced Drug Delivery Reviews
Volume54
Issue number2
DOIs
StatePublished - Feb 21 2002

Fingerprint

Poloxamer
Genetic Therapy
Transgenes
Gene Transfer Techniques
Drug Compounding
Pharmacopoeias
Excipients
Therapeutic Uses
Pharmaceutical Preparations
Skeletal Muscle
Peptides
Research
Genes

Keywords

  • Block copolymer
  • DNA
  • Gene delivery
  • Gene therapy
  • Poly(ethylene glycol)
  • Polycation

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Pluronic® block copolymers : Novel functional molecules for gene therapy. / Kabanov, Alexander V.; Lemieux, Pierre; Vinogradov, Sergey; Alakhov, Valery.

In: Advanced Drug Delivery Reviews, Vol. 54, No. 2, 21.02.2002, p. 223-233.

Research output: Contribution to journalArticle

Kabanov, Alexander V. ; Lemieux, Pierre ; Vinogradov, Sergey ; Alakhov, Valery. / Pluronic® block copolymers : Novel functional molecules for gene therapy. In: Advanced Drug Delivery Reviews. 2002 ; Vol. 54, No. 2. pp. 223-233.
@article{fcd8d4b61e904910ae5b7714a4759980,
title = "Pluronic{\circledR} block copolymers: Novel functional molecules for gene therapy",
abstract = "Pluronic{\circledR} block copolymers are recognized pharmaceutical excipients listed in the US and British Pharmacopoeia. They have been used extensively in a variety of pharmaceutical formulations including delivery of low molecular mass drugs and polypeptides. This review describes novel applications of Pluronic{\circledR} block copolymers in gene therapy. In particular, these molecules can modify the biological response during gene therapy in the skeletal muscle, resulting in an enhancement of the transgene expression as well as an enhancement of the therapeutic effect of the transgene. Furthermore, Pluronic{\circledR} block copolymers are versatile molecules that can be used as structural elements of the polycation-based gene delivery systems (polyplexes). Based on these studies, the use of block copolymers in gene delivery is a promising area of research, in which new and important developments are expected.",
keywords = "Block copolymer, DNA, Gene delivery, Gene therapy, Poly(ethylene glycol), Polycation",
author = "Kabanov, {Alexander V.} and Pierre Lemieux and Sergey Vinogradov and Valery Alakhov",
year = "2002",
month = "2",
day = "21",
doi = "10.1016/S0169-409X(02)00018-2",
language = "English (US)",
volume = "54",
pages = "223--233",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Pluronic® block copolymers

T2 - Novel functional molecules for gene therapy

AU - Kabanov, Alexander V.

AU - Lemieux, Pierre

AU - Vinogradov, Sergey

AU - Alakhov, Valery

PY - 2002/2/21

Y1 - 2002/2/21

N2 - Pluronic® block copolymers are recognized pharmaceutical excipients listed in the US and British Pharmacopoeia. They have been used extensively in a variety of pharmaceutical formulations including delivery of low molecular mass drugs and polypeptides. This review describes novel applications of Pluronic® block copolymers in gene therapy. In particular, these molecules can modify the biological response during gene therapy in the skeletal muscle, resulting in an enhancement of the transgene expression as well as an enhancement of the therapeutic effect of the transgene. Furthermore, Pluronic® block copolymers are versatile molecules that can be used as structural elements of the polycation-based gene delivery systems (polyplexes). Based on these studies, the use of block copolymers in gene delivery is a promising area of research, in which new and important developments are expected.

AB - Pluronic® block copolymers are recognized pharmaceutical excipients listed in the US and British Pharmacopoeia. They have been used extensively in a variety of pharmaceutical formulations including delivery of low molecular mass drugs and polypeptides. This review describes novel applications of Pluronic® block copolymers in gene therapy. In particular, these molecules can modify the biological response during gene therapy in the skeletal muscle, resulting in an enhancement of the transgene expression as well as an enhancement of the therapeutic effect of the transgene. Furthermore, Pluronic® block copolymers are versatile molecules that can be used as structural elements of the polycation-based gene delivery systems (polyplexes). Based on these studies, the use of block copolymers in gene delivery is a promising area of research, in which new and important developments are expected.

KW - Block copolymer

KW - DNA

KW - Gene delivery

KW - Gene therapy

KW - Poly(ethylene glycol)

KW - Polycation

UR - http://www.scopus.com/inward/record.url?scp=0037148596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037148596&partnerID=8YFLogxK

U2 - 10.1016/S0169-409X(02)00018-2

DO - 10.1016/S0169-409X(02)00018-2

M3 - Article

C2 - 11897147

AN - SCOPUS:0037148596

VL - 54

SP - 223

EP - 233

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 2

ER -